⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL913504 | 1.00 | — | — | |
| SCHEMBL9081638 | 1.00 | — | — | |
| SCHEMBL3490626 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL2670495 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL1543632 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL3490629 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL1543362 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL19295530 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL31049605 | 0.87 | CYP2C19 (0.35) | — | |
| SCHEMBL13913146 | 0.84 | ATM (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462358-A | Process method for synthesizing trans-3-hydroxycyclobutane carboxylic acid | 大连双硼医药化工有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-3684775-B1 | SUBSTITUTED DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | UNION THERAPEUTICS AS (DK) | 2024-11-20 | — | — | EP | claimed |
| CN-114980550-B | Circuit board ink stripping agent and circuit board ink stripping method | 昆山市板明电子科技有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115224271-A | Method for in-situ construction of zinc cathode artificial interface layer by simple soaking method | 南通大学 | 2022-10-21 | — | — | CN | claimed |
| CN-114980550-A | Circuit board ink stripping agent and circuit board ink stripping method | 昆山市板明电子科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| EP-3551633-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2021-03-31 | — | — | EP | claimed |
| CN-108129288-B | Synthesis method of trans-3-hydroxycyclobutylformic acid | 上海毕得医药科技股份有限公司 | 2021-01-22 | — | — | CN | claimed |
| CN-111108109-A | Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | 利奥制药有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-105968304-B | A kind of high-performance water-based polyurethane curing agent and the preparation method and application thereof | 华南理工大学 | 2018-09-14 | — | — | CN | claimed |
| CN-108129288-A | A kind of synthetic method of trans- -3- hydroxycyclobutyls formic acid | 上海毕得医药科技有限公司 | 2018-06-08 | — | — | CN | claimed |
| CN-107903161-A | A kind of synthetic method of cis 3 hydroxycyclobutyl formic acid | 上海毕路得医药科技有限公司 | 2018-04-13 | — | — | CN | claimed |
| CN-105968304-A | High-performance waterborne polyurethane curing agent and preparing method and application thereof | 华南理工大学 | 2016-09-28 | — | — | CN | claimed |
| EP-1987036-A1 | HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-11-05 | — | — | EP | claimed |
| WO-2007093520-A1 | HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-23 | — | — | WO | claimed |
| US-20070191335-A1 | 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease | ROCHE PALO ALTO LLC | 2007-08-16 | — | — | US | claimed |
| WO-2026098644-A1 | TARGETED PROTEIN DEGRADATION AGENT, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 北京森妙生物科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| US-12624028-B2 | 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2026-05-12 | — | — | US | disclosed |
| WO-1997028161-A1 | NOVEL PYRROLO[2,3-D]PYRIMIDINES AND THEIR USE AS TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 1997-08-07 | — | — | WO | disclosed |
| EP-0693054-A1 | CYCLOALKYLHYDROXYUREAS AND THEIR USE AS LIPOXYGENASE INHIBITORS | PFIZER INC. (US) | 1996-01-24 | — | — | EP | disclosed |
| WO-1994022814-A1 | CYCLOALKYLHYDROXYUREAS AND THEIR USE AS LIPOXYGENASE INHIBITORS | PFIZER INC. (US) | 1994-10-13 | — | — | WO | disclosed |